Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran

Iranian Journal of Kidney Diseases

Volumn 4, Issue 1, 2010, Pages 20-26

  Saddadi, Fereshteh ^a   Najafi, Iraj ^a   Hakemi, Monir Sadat ^a   Falaknazi, Kianoosh ^a   Attari, Fatemeh ^a   Bahar, Babak ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute kidney injury; Amphotericin B; Bone marrow transplantation; Cyclosporine A

Indexed keywords

AMIKACIN; AMPHOTERICIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; BUSULFAN; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; METHOTREXATE; PREDNISONE; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; COMORBIDITY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; IRAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUTROPENIA; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PROPHYLAXIS; RISK FACTOR; SCHOOL CHILD; VEIN OCCLUSION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INPATIENTS; IRAN; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, ACUTE; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 75649097484     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hingorani SR, Guthrie K, Batchelder A, et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int. 2005;67:272-7.
2. Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int. 1996;50:1026-31.
3. Jennette JC, Olson JL, Schwartz MM. Heptinstall's pathology of the kidney. Philadelphia: Lippincott-Raven; 2006.
4. Parikh CR, McSweeney PA, Korular D, et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002;62:566-73.
5. Sato N, Kishi K, Yagisawa K, et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease. Bone Marrow Transplant. 1995;16:303-5.
6. Walker JV, Morich D, Anasetti C. Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis. 1995;26:532-4.
7. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int. 2006;69:430-5.
8. Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant. 1999;23:99-101.
9. Zager RA, O'Quigley J, Zager BK, et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis. 1989;13:210-6.
10. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int. 1994;46:1443-58.
11. Bergstein J, Andreoli SP, Provisor AJ, Yum M. Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation. 1986;41:63-6.
12. Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, et al. Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplant. 1988;3:357-62.
13. Yabana M, Takagi N, Kihara M, et al. [A case of nephrotic syndrome after bone marrow transplantation]. Nippon Jinzo Gakkai Shi. 1997;39:414-20. Japanese.
14. Suehiro T, Masutani K, Yokoyama M, et al. Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin Nephrol. 2002;58:231-7.
15. Kimura S, Horie A, Hiki Y, et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood. 2003;101:4219-21.
16. Fuge R, Bird JM, Fraser A, et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol. 2001;113:58-64.
17. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant. 1998;22:351-7.
18. Uderzo C, Fumagalli M, De Lorenzo P, et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant. 2000;26:1005-9.
19. Lewis RM, Armstrong MY, Andre-Schwartz J, Muftuoglu A, Beldotti L, Schwartz RS. Chronic allogeneic disease. I. Development of glomerulonephritis. J Exp Med. 1968;128:653-79.
20. Bruijn JA, van Elven EH, Hogendoorn PC, Corver WE, Hoedemaeker PJ, Fleuren GJ. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988;130:639-41.
21. Bruijn JA, Bergijk EC, de Heer E, Fleuren GJ, Hoedemaeker PJ. Induction and progression of experimental lupus nephritis: exploration of a pathogenetic pathway. Kidney Int. 1992;41:5-13.
22. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today. 1991;12:223-7.
23. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652-9.
24. Rolink AG, Radaszkiewicz T, Melchers F. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice. J Exp Med. 1987;165:1675-87.
25. Rolink AG, Thalmann P, Berger C, Radaszkiewicz T, Melchers F. Autoreactive B-cell repertoire in mice with chronic graft versus host disease. Mol Immunol. 1988;25:1217-22.
26. Portanova JP, Arndt RE, Kotzin BL. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin. J Immunol. 1988;140:755-60.
27. Nergizoglu G, Keven K, Ates K, et al. Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol Dial Transplant. 1999;14:2461-3.
28. Lin J, Markowitz GS, Nicolaides M, et al. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol. 2001;21:351-6.
29. Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation. 1983;35:211-5.
30. Fadia A, Casserly LF, Sanchorawala V, et al. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int. 2003;63:1868-73.